LBHD1

Across TCGA pan-cancer cohorts, LBHD1 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated LBHD1 data layer compared with 20 for mass-spec protein and 3 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher LBHD1 mass-spec protein is associated with worse disease-free survival. In most high-consensus cancer types, elevated LBHD1 expression acts as an unfavorable survival marker, although some lineages such as GBM show a favorable association.

PDAC and GBM are the cancer types where LBHD1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	DFS	Median	All	0.192	0.554	.018	8	view →
GBM	DFS	Median	All	0.679	0.298	.035	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

LBHD1–PDAC (DFS)

Open the PDAC breakdown →